Appendix 4C and Activities Report - December 2022 Quarter
Filed with ASX ·
6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Webcast link correction - JP Morgan Conference Presentation
- ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU
- Telix Acquires Optimal Tracers
- ZIRCON Ph III Imaging Study - Top-Line data presentation
- ZIRCON Ph III Imaging Study - Positive Top-Line Results
Later from Telix Pharmaceuticals
- Q4 2022 Business update to accompany quarterly results
- Telix Full Year Results and Investor Conference Call Details
- 2022 Full Year Results Release
- Appendix 4E and 2022 Annual Report
- 2022 Full Year Results Presentation
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals